A Study of ML-004 in Adolescents and Adults with Autism Spectrum Disorder

  • Ages 12-45.
  • Diagnosis of autism spectrum disorder.
  • Able to attend all visits with a study partner.
  • Verbal and able to swallow a capsule.
  • If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial.
  • Open-label study to follow.
  • Method of Administration :  Oral / Capsule
    • Length/Duration: 12 weekly / biweekly visits
    • Location: 721 North Magnolia Avenue, Orlando FL 32803
    • Compensation: $50 / visit
    • Participants may:
      • See a doctor or medical staff at no cost
      • Have access to trial medications
      • Receive compensation for time and travel

Learn More About Participating in a Study

  • This field is for validation purposes and should be left unchanged.